Skip to main content

Table 6 Comparisons of pro-inflammatory and anti-inflammatory cytokines in BALF and blood between survivors and non-survivors of pure PJP patients

From: The impact of concomitant pulmonary infection on immune dysregulation in Pneumocystis jirovecii pneumonia

 

Survivor (N =28)

Non-survivor (N =19)

P value*

P value#

BALF

    

  IL-1β, pg/ml

2.21(1.68;3.51)

2.00(1.50;2.91)

0.948

 

  TNF-α, pg/ml

10.07(7.98;14.05)

10.10(9.07;11.60)

0.761

 

  IL-8, pg/ml

35.63(22.60;79.26)

114.80(36.70;375.60)

0.010

0.694

  IL-17, pg/ml

15.00(15.00;15.00)

15.00(15.00;15.00)

0.751

 

  MCP-1, pg/ml

736.49(218.78;2703.81)

1065.50(344.00;3069.70)

0.474

 

  IL-10, pg/ml

4.61(3.90;8.89)

3.90(3.90;4.40)

0.079

 

  TGF-β1, pg/ml

53.40(43.00;194.80)

48.80(41.20;54.13)

0.094

 

  IL-1RA, pg/ml

1589.90(669.20;3178.55)

1077.40(512.40;1870.50)

0.254

 

  IL-1β/IL-10

0.41(0.28;0.56)

0.49(0.36;0.57)

0.293

 

  TNF-α/IL-10

2.33(1.15;2.63)

2.51(2.20;2.71)

0.193

 

  IL-8/IL-10

8.26(3.66;13.75)

17.79(8.90;54.86)

0.002

0.735

  IL-17/IL-10

3.85(3.48;3.85)

3.85(2.27;3.85)

0.451

 

  MCP-1/ IL-10

112.85(39.67;334.84)

273.21(79.44;433.15)

0.146

 

  IL-1β/TGF-β1

0.03(0.00;0.05)

0.04(0.03;0.06)

0.042

0.611

  TNF-α/TGF-β1

0.15(0.01;0.26)

0.21(0.18;0.25)

0.091

 

  IL-8/TGF-β1

0.51(0.13;1.03)

1.56(0.71;7.73)

0.001

0.018

  IL-17/TGF-β1

0.28(0.23;0.41)

0.31(0.27;0.36)

0.505

 

  MCP-1/TGF-β1

6.09(0.54;39.10)

21.57(5.49;58.27)

0.044

0.486

  IL-1β/IL-1RA

0.00(0.00;0.00)

0.00(0.00;0.01)

0.451

 

  TNF-α/IL-1RA

0.01(0.00;0.02)

0.01(0.00;0.02)

0.354

 

  IL-8/IL-1RA

0.04(0.01;0.09)

0.12(0.03;0.53)

0.033

0.517

  IL-17/IL-1RA

0.01(0.00;0.03)

0.01(0.01;0.03)

0.591

 

  MCP-1/IL-1RA

0.28(0.18;1.14)

1.48(0.46;4.43)

0.012

0.329

Blood

    

  TNF-α, pg/ml

11.10(8.56;18.20)

13.35(10.03;16.45)

0.335

 

  IL-8, pg/ml

23.65(16.53;41.55)

47.10(26.80;136.60)

0.002

0.397

  IL-17, pg/ml

15.00(15.00;15.00)

15.00(15.00;15.00)

0.781

 

  MCP-1, pg/ml

1287.20(374.63;2124.20)

1014.60(529.10;2683.20)

0.537

 

  IL-10, pg/ml

14.05(8.78;26.62)

33.00(11.60;47.10)

0.018

0.952

  TGF-β1, pg/ml

1020.85(245.89;10269.20)

423.40(205.00;6450.50)

0.515

 

  IL-1RA, pg/ml

1678.75(695.58;3536.63)

565.70(271.33;1594.93)

0.036

 

  IL-8/IL-10

1.74(0.81;2.45)

1.73(1.25;4.05)

0.423

 

  IL-8/TGF-β1

0.03(0.00;0.12)

0.12(0.02;0.24)

0.054

 

  TNF-α/IL-10

0.93(0.43;1.23)

0.45(0.24;0.80)

0.083

 

  TNF-α/TGF-β1

0.01(0.00;0.06)

0.05(0.00;0.09)

0.273

 
  1. Data are expressed as median IQR (25%;75%).
  2. BALF = Bronchoalveolar lavage fluid; PJP = Pneumocystis jirovecii pneumonia; IL = Interleukin; TGF-β1 = Transforming growth factor-β1; TNF-α = Tumor necrosis factor-α; MCP-1 = Monocyte chemoattractant protein-1; IL-1RA = IL-1 receptor antagonist.
  3. The comparison was made by Mann–Whitney U test.
  4. P*:univariate analysis, P#:multivariate analysis.